Cancer surveillance following orthotopic liver transplantation.
With the success of liver transplantation, the number of recipients continues to grow each year. Many of these patients have an increased risk for gastrointestinal malignancies. This article provides a rational basis for surveillance of gastrointestinal malignancies in the liver transplant recipient.
Trotter
J F
JF
Division of Gastroenterology/Hepatology, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA. james.trotter@uchsc.edu
D001005:Anus Neoplasms / Q000175:diagnosis; D006528:Carcinoma, Hepatocellular / Q000601:surgery; D015209:Cholangitis, Sclerosing / Q000150:complications; D003093:Colitis, Ulcerative / Q000150:complications; D003110:Colonic Neoplasms / Q000175:diagnosis / Q000209:etiology; D003113:Colonoscopy; D004938:Esophageal Neoplasms / Q000175:diagnosis / Q000517:prevention & control; D005770:Gastrointestinal Neoplasms / Q000175:diagnosis* / Q000209:etiology* / Q000517:prevention & control; D006525:Hepatitis, Viral, Human / Q000209:etiology; D006801:Humans; D008113:Liver Neoplasms / Q000601:surgery; D016031:Liver Transplantation; D016609:Neoplasms, Second Primary / Q000175:diagnosis* / Q000517:prevention & control; D011183:Postoperative Complications / Q000175:diagnosis* / Q000517:prevention & control; D011184:Postoperative Period